Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
101M
-
Number of holders
-
202
-
Total 13F shares, excl. options
-
55.8M
-
Shares change
-
+1.29M
-
Total reported value, excl. options
-
$2.18B
-
Value change
-
+$43.3M
-
Put/Call ratio
-
2
-
Number of buys
-
107
-
Number of sells
-
-89
-
Price
-
$39.11
Significant Holders of Beam Therapeutics Inc. - Common Stock (BEAM) as of Q4 2022
255 filings reported holding BEAM - Beam Therapeutics Inc. - Common Stock as of Q4 2022.
Beam Therapeutics Inc. - Common Stock (BEAM) has 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.8M shares
of 101M outstanding shares and own 55.47% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (8.21M shares), VANGUARD GROUP INC (6.27M shares), BlackRock Inc. (5.24M shares), FMR LLC (4.97M shares), FARALLON CAPITAL MANAGEMENT LLC (3.4M shares), STATE STREET CORP (3.09M shares), Temasek Holdings (Private) Ltd (2.88M shares), MWG Management Ltd. (2.35M shares), Redmile Group, LLC (1.77M shares), and Deep Track Capital, LP (1.17M shares).
This table shows the top 202 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.